Bio-Rad Laboratories (NYSE:BIO.B – Get Free Report) is set to issue its quarterly earnings data after the market closes on Wednesday, October 30th.
Bio-Rad Laboratories (NYSE:BIO.B – Get Free Report) last issued its quarterly earnings results on Thursday, August 1st. The company reported $3.11 earnings per share (EPS) for the quarter. Bio-Rad Laboratories had a negative net margin of 51.73% and a positive return on equity of 3.77%. The company had revenue of $638.48 million during the quarter.
Bio-Rad Laboratories Stock Performance
NYSE:BIO.B opened at $334.85 on Tuesday. The firm has a market capitalization of $9.55 billion, a P/E ratio of -32.32 and a beta of 0.73. The company has a debt-to-equity ratio of 0.18, a current ratio of 6.28 and a quick ratio of 4.63. Bio-Rad Laboratories has a one year low of $271.00 and a one year high of $352.91. The company’s 50-day simple moving average is $329.69 and its 200 day simple moving average is $304.75.
About Bio-Rad Laboratories
Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.
Further Reading
- Five stocks we like better than Bio-Rad Laboratories
- What are earnings reports?
- Inflation Risk Rising, Key Trades Investors Are Making Now
- 3 Ways To Invest In Coffee, Other Than Drinking It
- 3 Oil Stocks to Watch Before Earnings Come Out
- The 3 Best Blue-Chip Stocks to Buy Now
- Is American Express Stock’s Sell-the-News Reaction a Buying Opp?
Receive News & Ratings for Bio-Rad Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bio-Rad Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.